3-Hydroxyphthaloyl-beta-lactoglobulin
Alternative Names: 3-hydroxyphthalic anhydride treated beta-lactoglobulin; 3HP-beta-LGLatest Information Update: 30 Apr 2002
At a glance
- Originator Nonindustrial source
- Class Antivirals
- Mechanism of Action HIV fusion inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Herpes simplex virus infections; HIV infections